Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

Aim of this monocentric retrospective observational study was to evaluate the 18-month effectiveness and safety of once weekly 1.5 mg GLP-1 receptor agonist (GLP-1 RA) dulaglutide (DU) as add-on to metformin (MET) or MET plus conventional insulin secretagogues (SFU/glinide) in a study cohort with ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabelli, Maria, Chiefari, Eusebio, Tocci, Vera, Puccio, Luigi, Foti, Daniela, Brunetti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089678/
http://dx.doi.org/10.1210/jendso/bvab048.680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089678/
http://dx.doi.org/10.1210/jendso/bvab048.680

Ejemplares similares